Abstract

Endoplasmic reticulum (ER)-mitochondria contacts are critical for the regulation of lipid transport, synthesis, and metabolism. However, the molecular mechanism and physiological function of endoplasmic reticulum-mitochondrial contacts remain unclear. Here, we show that Mic19, a key subunit of MICOS (mitochondrial contact site and cristae organizing system) complex, regulates ER-mitochondria contacts by the EMC2-SLC25A46-Mic19 axis. Mic19 liver specific knockout (LKO) leads to the reduction of ER-mitochondrial contacts, mitochondrial lipid metabolism disorder, disorganization of mitochondrial cristae and mitochondrial unfolded protein stress response in mouse hepatocytes, impairing liver mitochondrial fatty acid β-oxidation and lipid metabolism, which may spontaneously trigger nonalcoholic steatohepatitis (NASH) and liver fibrosis in mice. Whereas, the re-expression of Mic19 in Mic19 LKO hepatocytes blocks the development of liver disease in mice. In addition, Mic19 overexpression suppresses MCD-induced fatty liver disease. Thus, our findings uncover the EMC2-SLC25A46-Mic19 axis as a pathway regulating ER-mitochondria contacts, and reveal that impairment of ER-mitochondria contacts may be a mechanism associated with the development of NASH and liver fibrosis.

The molecular mechanism and physiological function of endoplasmic reticulum-mitochondrial contacts remain unclear. Here, authors uncover a role for the EMC2- SLC25A46-Mic19 axis in mitochondrial lipid metabolism and liver disease

Details

Title
Mic19 depletion impairs endoplasmic reticulum-mitochondrial contacts and mitochondrial lipid metabolism and triggers liver disease
Author
Dong, Jun 1 ; Chen, Li 2   VIAFID ORCID Logo  ; Ye, Fei 1 ; Tang, Junhui 1 ; Liu, Bing 1 ; Lin, Jiacheng 1 ; Zhou, Pang-Hu 1 ; Lu, Bin 3 ; Wu, Min 1   VIAFID ORCID Logo  ; Lu, Jia-Hong 4   VIAFID ORCID Logo  ; He, Jing-Jing 5 ; Engelender, Simone 6 ; Meng, Qingtao 1 ; Song, Zhiyin 2   VIAFID ORCID Logo  ; He, He 2   VIAFID ORCID Logo 

 Renmin Hospital of Wuhan University, Wuhan University, College of Life Sciences, TaiKang Center for Life and Medical Sciences, Frontier Science Center for Immunology and Metabolism, Department of Anesthesiology, Wuhan, China (GRID:grid.49470.3e) (ISNI:0000 0001 2331 6153) 
 Renmin Hospital of Wuhan University, Wuhan University, College of Life Sciences, TaiKang Center for Life and Medical Sciences, Frontier Science Center for Immunology and Metabolism, Department of Anesthesiology, Wuhan, China (GRID:grid.49470.3e) (ISNI:0000 0001 2331 6153); Huazhong University of Science and Technology, Department of pathology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Wuhan, China (GRID:grid.33199.31) (ISNI:0000 0004 0368 7223) 
 University of South China, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Hengyang Medical School, Hengyang, China (GRID:grid.412017.1) (ISNI:0000 0001 0266 8918) 
 University of Macau, State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, Macau, China (GRID:grid.437123.0) (ISNI:0000 0004 1794 8068) 
 Anhui Provincial Children’s Hospital, Department of Pediatric Intensive Care Unit, Hefei, China (GRID:grid.489986.2) (ISNI:0000 0004 6473 1769) 
 Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Department of Biochemistry, Haifa, Israel (GRID:grid.6451.6) (ISNI:0000 0001 2110 2151) 
Pages
168
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2909041506
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.